Back to Archived News
Techalt, Inc. Announces Petition for Revival of the Patent Application for Stan’s Rodeo Ointment
Thursday, June 05, 2008
Seattle, WA -- Techalt, Inc. (Pink Sheets:TCLT) ("Techalt" or "Company") announced that the petition for revival of the patent application filed with the US Patent and Trademark Office ("USPTO"), covering the formulations and processing of Stan’s Rodeo Ointment ("SRO"), has been submitted and received by the USPTO following the unintentional abandonment of the patent under 37 CFR 1.137(b). SRO expects the completion of the re-activation of the patent application process within 6-8 weeks.
Techalt is currently in the process of securing financing for expanding SRO’s distribution channels, which includes securing significant contracts, and getting over the counter ("OTC") approval from the Food and Drug Administration.
SRO is a sports cream product that can accelerate the healing time for abrasions, lacerations, blisters and other open wounds to the skin, while diminishing the pain that often results from such injuries. Developed by Stanley Johnston, former head athletic trainer for the Los Angeles Dodgers, SRO is currently available by prescription and used by several prominent Olympic and professional athletes. Techalt also acquired the rights to develop Stan’s Blister Rub ("SBR"), which is a combination of materials that strengthen the skin after it has healed to reduce the likelihood of the reoccurrence of blisters to the applied area. Patent protection has been filed covering the formulations and processing of SRO with the US Patent and Trademark Office with a patent expected in May 2008.
Techalt’s business model as a public holding company is to pursue quality opportunities in developing early to mid-stage alternative technology, communications, environmental and health and wellness companies.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("the Exchange Act"), as such, may involve risks and uncertainties. Forward-looking statements are based upon certain assumptions and describe future plans, strategies and expectations, are generally identifiable by the use of words as "believe," "expect," "intend," "anticipate," "project," or other similar expressions. Forward-looking statements relate to, among other things, future performance, and perceived opportunities in the market and statements regarding the Company's mission and vision. The Company's actual results, performance and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements. Additional factors could materially affect these forward-looking statements and/or predictions include, among other things: (1) managing acquisitions and expansion of operations; (2) obtaining necessary financing and managing existing debt; (3) completing the investigation, acquisition and integration of new business opportunities; (4) complying with federal, state and local government and international regulations; and (5) other factors over which we have little or no control.
Back to Archived News
